Physician profile
James Klein
NPI 1104828482
$11,741.21
in general payments reported to CMS, 2019-2025
26 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $864 · 2020: $157 · 2021: $108 · 2022: $9,235 · 2023: $600 · 2024: $475 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $9,066.79 | 2021-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Regeneron Healthcare Solutions, INC. | $612.68 | 2019-2025 | Eylea Hd, Eylea |
| Sun Pharmaceutical Industries INC. | $343.60 | 2019-2023 | Cequa |
| Alcon Vision LLC | $321.64 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity, Clareon |
| Bausch & Lomb Americas INC. | $295.97 | 2023-2025 | Miebo, Vyzulta, Envista Mx60 Iol |
| Johnson & Johnson Surgical Vision, INC. | $155.99 | 2019-2024 | Tecnis Iol |
| Allergan, INC. | $150.60 | 2019-2022 | |
| Shire North American Group INC | $139.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $120.99 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.95 | 2019-2020 | |
| Omeros Corporation | $49.95 | 2019 | |
| Dompe US, INC. | $45.71 | 2022-2025 | Oxervate |
| Genentech USA, INC. | $41.97 | 2024 | Vabysmo |
| Harrow Eye, LLC | $39.51 | 2023-2025 | Vevye, Iheezo |
| Abbvie INC. | $35.35 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $33.76 | 2022-2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Kala Pharmaceuticals, INC. | $32.51 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $28.55 | 2019 | |
| Oyster Point Pharma, INC. | $26.28 | 2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $24.07 | 2024 | Xdemvy |
| Lombart Brothers, INC. | $20.13 | 2021 | |
| Biotissue Holdings INC. | $17.93 | 2023 | |
| Thea Pharma INC. | $15.61 | 2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $14.62 | 2022 | |
| Carl Zeiss Meditec, INC. | $14.33 | 2019 | |
| Eyepoint US, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.